lateonset hypogonadism loh testosterone deficiency syndrome condition older men characterized measurably low testosterone levels clinical symptoms mostly sexual nature including decreased desire sex fewer spontaneous erections erectile result gradual drop testosterone steady decline testosterone levels per year happen well documented men men present symptoms normal testosterone levels others low testosterone levels symptoms reasons phenomenon currently late early men may experience depression loss libido erectile dysfunction physical emotional symptoms symptoms include irritability loss muscle mass reduced ability exercise weight gain lack energy difficulty sleeping poor concentration important note many symptoms may arise midlife crisis results longterm unhealthy lifestyle smoking excess drinking overeating lack exercise may best addressed lifestyle changes therapy testosterone levels welldocumented decline aging per year men women certain age causes well international society study aging male defines lateonset hypogonadism series symptoms older adults related testosterone deficiency combines features primary secondary hypogonadism european male aging study prospective study defined condition presence least three sexual symptoms eg reduced libido reduced spontaneous erections erectile dysfunction total testosterone concentrations less nmoll ngml free testosterone concentrations less pmoll person symptoms lateonset hypogonadism testosterone measured taking blood morning least two days immunoassays commonly used mass spectrometry accurate becoming widely meaning measurement different depending many factors affect testosterone made carried blood increased concentrations proteins bind testosterone blood occur person older hyperthyroidism liver disease taking anticonvulsant drugs increasingly used depression various neuropathies decreased concentrations proteins bind testosterone occur person obese diabetes hypothyroidism liver disease taking glucocorticoids androgens levels low conditions cause primary secondary hypogonadism need ruled due difficulty expense testing ambiguity results screening clinical instruments standard surveys developed specificity low useful significance decrease testosterone levels debated treatment replacement controversial food drug administration fda stated neither benefits safety testosterone established older men low testosterone testosterone replacement therapy started low levels us confirmation done time testosterone levels also monitored adverse effects testosterone supplementation may include increased cardiovascular cv events including strokes heart attacks deaths especially men men preexisting heart potential cv risks testosterone therapy led fda issue requirement testosterone pharmaceutical labels include warning information possibility increased risk heart attacks however data mixed european medicines agency american association clinical endocrinologists american college endocrinology stated consistent evidence shows testosterone therapy either increases decreases cardiovascular significant adverse effects testosterone supplementation include acceleration preexisting prostate cancer growth increased hematocrit require venipuncture treat exacerbation sleep adverse effects may also include minor side effects acne oily skin well significant hair loss andor thinning hair may prevented reductase inhibitors ordinarily used treatment benign prostatic hyperplasia finasteride exogenous testosterone may also cause suppression spermatogenesis leading cases evidence inconclusive whether testosterone replacement therapy help erectile dysfunction men lateonset appears testosterone replacement therapy may benefit men symptoms frailty lateonset epidemiology clear men men low around men low testosterone symptoms diagnosed lateonset uk national health service describes impact low levels testosterone previously reported heller myers identified symptoms labeled male climacteric including loss libido potency nervousness depression impaired memory inability concentrate fatigue insomnia hot flushes sweating heller myers found subjects lower normal levels testosterone symptoms decreased dramatically patients given replacement doses book male jed diamond psychologist phd international fueled popular interest concept andropausecitation needed diamond regards andropause change life middleaged men hormonal physical psychological interpersonal social sexual spiritual aspects diamond claims change occurs men may occur early age dramatically age men womens mens experiences somewhat similar medical community rejected term andropause supposed parallels thomas perls david j handelsman editorial journal american geriatrics society say illdefined nature diagnosis pressure advertising drug companies selling testosterone humangrowth hormone well dietary supplement companies selling kinds boosters aging men condition overdiagnosed perls handelsman note us sales testosterone increased million billion number testosterone doses prescribed climbed million half billion including additional contributions compounding pharmacies internet directtopatient clinic lateonset hypogonadism endocrine condition well result terms male menopause andropause used popular media misleading imply sudden change hormone levels similar women experience decrease libido men result age sometimes colloquially referred research necessary find better ways measure testosterone better able understand measurements given person understand people low testosterone present symptoms seemingly adequate levels present research also necessary better understand cardiovascular risks testosterone replacement therapy older relationship lateonset hypogonadism risk alzheimers disease hypothesized small clinical studies conducted investigate prevention alzheimers disease men lateonset hypogonadism results httpsenwikipediaorgwikilateonsethypogonadism